Pharmaceutical Fluid Handling Market Report 2026

The pharmaceutical fluid handling market size has grown strongly in recent years. It will grow from $12.35 billion in 2025 to $13.06 billion in 2026 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to increasing biologics manufacturing activities, rising need for precise fluid dosing, expansion of sterile drug production, adoption of modular manufacturing layouts, increased focus on product quality assurance.

The pharmaceutical fluid handling market size is expected to see strong growth in the next few years. It will grow to $16.63 billion in 2030 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to increasing investments in continuous manufacturing, rising adoption of automation in fluid processing, expansion of personalized medicine production, growing demand for scalable fluid handling solutions, increasing regulatory focus on contamination prevention. Major trends in the forecast period include increasing adoption of single-use fluid handling systems, rising demand for high-purity tubing and components, growing integration of automated fluid management solutions, expansion of closed-system processing technologies, enhanced focus on contamination control.

The increase in pharmaceutical drug production is expected to drive the growth of the pharmaceutical fluid handling market in the coming years. Drug production involves the manufacturing of pharmaceutical substances, medicines, or drugs. Pharmaceutical fluid handling supports drug production by enabling precise, efficient handling, transfer, and containment of liquids throughout the manufacturing process. For instance, in June 2023, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association representing the pharmaceutical industry in Europe, total pharmaceutical production in Europe reached €390.0 billion ($422,803 million) in 2023, up from €363.3 billion ($393,857 million) in 2022. Therefore, the increasing demand for pharmaceutical drugs is contributing to the growth of the pharmaceutical fluid handling market.

Major companies operating in the pharmaceutical fluid handling market are concentrating on the development of robotic technologies to enhance fluid handling processes. The integration of automation and robotics into fluid handling systems improves efficiency, accuracy, and consistency across pharmaceutical manufacturing operations. For example, in May 2023, Cellular Origins, a UK-based manufacturer specializing in automated cell and gene therapy solutions, launched Constellation A, a closed, fully automated, and configurable robotic platform designed for cell therapy applications. This platform enables complete end-to-end digital integration, including remote digital control, analytics, and quality control systems.

In October 2024, Plastic Design Corporation (PDC), a US-based manufacturer of precision micromolded components and services for medical devices, acquired Resenex for an undisclosed amount. This acquisition is expected to strengthen PDC’s capability to deliver advanced, dependable, and scalable fluid management solutions, reinforcing its focus on innovation and customer value. Resenex is a US-based provider of fluid management solutions serving the healthcare and biotechnology industries.

Major companies operating in the pharmaceutical fluid handling market are Thermo Fisher Scientific Inc., Danaher Corporation, Parker Hannifin Corporation, Corning Incorporated, Agilent Technologies Inc., Alfa Laval AB, PerkinElmer Inc., Spirax Sarco Engineering plc, Eppendorf AG, Tecan Trading AG, CIRCOR International Inc., Raumedic AG, Borosil Glass Works Ltd., BioTek Instruments Inc., Labcyte Inc., Gilson Company Inc., Aurora Biomed Inc., Tef Cap Industries Inc., Labnet International Inc., Australian Fluid Handling Pty Ltd., Fraser Ross Ltd., Sartorius AG, Watson-Marlow Fluid Technology Group, Saint-Gobain Life Sciences, IDEX Corporation.

North America was the largest region in the pharmaceutical fluid handling market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical fluid handling market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pharmaceutical fluid handling market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the pharmaceutical fluid handling market by increasing costs of imported pumps, valves, silicone tubing, filters, and flow control components used in sterile manufacturing processes. Pharmaceutical manufacturing hubs in North America and Europe are most affected due to reliance on imported high-specification components, while Asia-Pacific faces pricing pressure on advanced material imports. These tariffs are raising system integration costs and extending project timelines. However, they are also encouraging local production of fluid handling components, regional supplier development, and innovation in cost-optimized single-use systems.

The pharmaceutical fluid handling market research report is one of a series of new reports that provides pharmaceutical fluid handling market statistics, including pharmaceutical fluid handling industry global market size, regional shares, competitors with a pharmaceutical fluid handling market share, detailed pharmaceutical fluid handling market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical fluid handling industry. This pharmaceutical fluid handling market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Pharmaceutical fluid handling involves the processes and systems used to control, transfer, and manage fluids within the pharmaceutical industry. These practices ensure accurate dosing, reduce the risk of contamination, and maintain the quality and integrity of pharmaceutical products throughout the manufacturing process.

The main offerings in pharmaceutical fluid handling include equipment and solutions, as well as services. Equipment and solutions consist of tools, machinery, systems, and integrated offerings developed to address specific operational requirements across different applications. The tubing materials used include thermoplastic elastomers, polyvinyl chloride, and silicone. These components support a range of uses such as cough syrups, intravenous products, complex active pharmaceutical ingredients, and others. Pharmaceutical fluid handling solutions are applied in areas including fluid handling and management, fluid preparation, integration and automation, buffer management, and other processes, and are utilized by end users such as biotechnology companies, pharmaceutical and medical companies, and others.

The pharmaceutical fluid handling market consists of revenues earned by entities by providing services such as fluid transfer, storage, filtration, mixing, blending, and dispensing of various liquids and solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharmaceutical fluid handling market also includes sales of pumps, micropipettes, valves, pipets, filters, mixers, stackers, washers, handlers, containers, and robotic systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.